In non-small cell lung cancer (NSCLC), simvastatin induced caspase-1 expression and activation, increases IL-18 and IL-1β release, and induced NSCLC cell pyroptosis (F. Wang et al. 2018). This evidence concerns the gene IL1B and non-small cell lung carcinoma.